Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 90.75%155.49M | 133.66%97.73M | 63.12%68.57M | 21.66%244.77M | 26.12%79.39M | 67.65%81.52M | -7.22%41.83M | -1.69%42.04M | 7.58%201.18M | 46.12%62.95M |
| Cost of revenue | 103.99%139.4M | 178.76%82.7M | 79.70%56.25M | 20.67%190.6M | 25.00%61.04M | 82.79%68.34M | -20.10%29.67M | -9.64%31.3M | -0.61%157.95M | 33.04%48.83M |
| Gross profit | 22.10%16.09M | 23.62%15.03M | 14.76%12.32M | 25.32%54.17M | 29.99%18.35M | 17.26%13.18M | 52.90%12.16M | 32.21%10.73M | 53.92%43.23M | 121.45%14.11M |
| Operating expense | 4.60%5M | 28.91%5.26M | -12.34%4.12M | -30.24%22.74M | -31.93%8.14M | -27.50%4.78M | -14.23%4.08M | -7.84%4.7M | 46.59%32.6M | 94.07%11.95M |
| Selling and administrative expenses | 4.60%5M | 28.91%5.26M | -12.34%4.12M | -16.03%22.74M | -31.93%8.14M | -27.50%4.78M | -14.23%4.08M | -7.84%4.7M | 22.44%27.08M | 97.96%11.95M |
| -General and administrative expense | 4.60%5M | 28.91%5.26M | -12.34%4.12M | -16.03%22.74M | -31.93%8.14M | -27.50%4.78M | -14.23%4.08M | -7.84%4.7M | 22.44%27.08M | 97.96%11.95M |
| Other operating expenses | ---- | ---- | ---- | -99.95%3K | ---- | ---- | ---- | ---- | 4,461.98%5.52M | ---- |
| Operating profit | 32.07%11.09M | 20.95%9.77M | 35.87%8.2M | 195.74%31.43M | 372.25%10.21M | 80.87%8.4M | 152.91%8.08M | 99.90%6.03M | 81.77%10.63M | 905.58%2.16M |
| Net non-operating interest income (expenses) | 8.24%-3.23M | -28.55%-2.9M | -22.91%-2.38M | -48.26%-7.97M | -2.76%-2.31M | -485.36%-3.52M | -54.83%-2.26M | -75.54%-1.94M | -62.15%-5.38M | -806.85%-2.25M |
| Non-operating interest income | ---- | ---- | ---- | 208.47%1.53M | ---- | ---- | ---- | ---- | -4.06%496K | ---- |
| Non-operating interest expense | -8.24%3.23M | 28.55%2.9M | 22.91%2.38M | 81.70%9.49M | 2.76%2.31M | 485.36%3.52M | 54.83%2.26M | 75.54%1.94M | 36.98%5.22M | 201.88%2.25M |
| Total other finance cost | ---- | ---- | ---- | -98.15%12K | ---- | ---- | ---- | ---- | 3,150.00%650K | ---- |
| Net investment income | 87.50%30K | 16K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -542K | 0 | ||||||||
| Special income (charges) | -89.34%748K | 321.31%7.02M | ||||||||
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -328.51%-7.02M | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---748K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -76.32%796K | -45.99%693K | 9.26%1.22M | 211.63%4.1M | -90.23%267K | -80.03%3.36M | -39.19%1.28M | 73.21%1.11M | 82.64%1.32M | 826.10%2.73M |
| Income before tax | -1.52%8.12M | 6.43%7.56M | 35.01%7.03M | 108.33%28.34M | 208.73%8.17M | -60.53%8.24M | 84.71%7.1M | 103.72%5.21M | 176.61%13.6M | 37.19%2.65M |
| Income tax | -87.73%256K | -34.13%1.12M | 875.56%878K | 305.89%6.34M | 2.88M | 273.35%2.09M | 236.29%1.71M | 550.00%90K | -26.55%1.56M | 0 |
| Net income | 27.73%7.86M | 19.25%6.44M | 20.23%6.15M | 82.68%21.99M | 100.04%5.29M | -69.72%6.15M | 61.68%5.4M | 98.64%5.12M | 331.62%12.04M | 442.01%2.65M |
| Net income continuous operations | 27.73%7.86M | 19.25%6.44M | 20.23%6.15M | 82.68%21.99M | 100.04%5.29M | -69.72%6.15M | 61.68%5.4M | 98.64%5.12M | 331.62%12.04M | 442.01%2.65M |
| Noncontrolling interests | -191.11%-41K | 68.82%-53K | -163.33%-95K | 179.03%519K | 252.03%433K | 209.76%45K | -1,114.29%-170K | 0.00%150K | 377.61%186K | 246.43%123K |
| Net income attributable to the company | 29.34%7.9M | 16.56%6.49M | 25.77%6.25M | 81.17%21.47M | 92.62%4.86M | -70.00%6.11M | 66.08%5.57M | 104.74%4.97M | 314.99%11.85M | 340.91%2.52M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 29.34%7.9M | 16.56%6.49M | 25.77%6.25M | 81.17%21.47M | 92.62%4.86M | -70.00%6.11M | 66.08%5.57M | 104.74%4.97M | 314.99%11.85M | 340.91%2.52M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 16.13%0.0036 | 10.71%0.0031 | 20.00%0.003 | 68.75%0.0108 | 76.92%0.0023 | -72.57%0.0031 | 47.37%0.0028 | 92.31%0.0025 | 300.00%0.0064 | 333.33%0.0013 |
| Diluted earnings per share | 28.57%0.0036 | 7.14%0.003 | 70.59%0.0029 | 151.22%0.0103 | 175.00%0.0022 | -58.82%0.0028 | 154.55%0.0028 | 112.50%0.0017 | 355.56%0.0041 | 0.0008 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.